AstraZeneca (AZN) Tops Q3 EPS by 20c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Nasdaq futures tumble as Amazon, Intel results deepen AI spending woes
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Oil set for fourth monthly gain as Hormuz tanker attack highlights supply risks
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
Tweet
Share
E-mail
Get Alerts AZN Hot Sheet
Join SI Premium – FREE
AstraZeneca (NASDAQ: AZN) reported Q3 EPS of $2.79, $0.20 better than the analyst estimate of $2.59. Revenue for the quarter came in at $16.21 billion versus the consensus estimate of $16.04 billion.
For earnings history and earnings-related data on AstraZeneca (AZN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lear Corp. (LEA) Tops Q3 EPS by 39c ; Offers Guidance
- Citizens Financial Services, Inc. (CZFS) Tops Q3 EPS by 28c
- Mastech Digital (MHH) Misses Q3 EPS by 1c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
